About NALPROPION PHARMACEUTICALS LLC
Currax is a pharmaceutical company focused on developing and providing innovative medicines for chronic progressive diseases, particularly in the area of obesity treatment. The company emphasizes patient-centric approaches and has a growing portfolio of therapies.
Development of innovative medicines for chronic progressive diseasesDirect-to-consumer (DTC) platform for obesity medicationsExpansion of manufacturing sites to ensure drug supplyEducational and advocacy campaigns around obesity treatment
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NALPROPION PHARMACEUTICALS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.